Stock listing

NASDAQ:TRAX First Tracks Biotherapeutics, Inc. Stock

Home listing (NASDAQ) of First Tracks Biotherapeutics, Inc.

Follow First Tracks Biotherapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:TRAX

$41.64 USD -2.86 (-6.4%)

Close on Nov 20, 2026

Since Mar 10, 2026 +228.7% · daily closes, Mar 10, 2026 – Nov 20, 2026, adjusted for splits
Day range
$41.51 – $44.51 USDNov 20, 2026
Volume
504,364 sharesNov 20, 2026
Market cap
$1.75B USDAt the close on Nov 20, 2026 · price × 42.02M shares outstanding
Traded on an average day
$32.33M USDMedian day 617,731 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:TRAX · Home$41.64 USD-2.86 (-6.4%)504,364$43.99$44.51$41.51$44.50Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:TRAX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$41.64-2.86-6.4%$43.99$44.51$41.51504,364
$44.50+0.93+2.1%$43.17$45.44$43.17751,346
$43.57-2.99-6.4%$46.04$46.71$43.06586,451
$46.56-0.54-1.1%$46.52$48.48$46.29438,162
$47.10-1.60-3.3%$48.54$48.72$46.58462,165
$48.70-1.83-3.6%$48.94$50.15$46.97311,332
$50.53-1.80-3.4%$52.40$53.75$49.57487,936
$52.33+2.63+5.3%$49.11$54.78$48.641,150,314
$49.70+1.80+3.8%$48.90$50.41$47.58808,489
$47.90+2.47+5.4%$45.94$48.24$45.44587,920
$45.43-3.61-7.4%$49.10$49.10$44.47571,287
$49.04+2.70+5.8%$48.01$50.16$46.09881,330
$46.34+1.29+2.9%$45.54$46.71$45.54410,048
$45.05-0.03-0.1%$46.05$46.37$43.32426,382
$45.08-0.145-0.3%$45.03$45.87$43.36434,124
$45.23-0.495-1.1%$46.18$47.55$44.05471,526
$45.72+0.34+0.7%$44.84$46.37$44.79640,962
$45.38+1.90+4.4%$43.90$46.08$43.27617,731
$43.48-0.57-1.3%$43.10$45.42$41.83592,253
$44.05+0.91+2.1%$43.13$44.78$41.60849,800
$43.14+0.37+0.9%$42.27$44.14$41.67844,300
$42.77+1.52+3.7%$41.20$42.89$40.00711,500
$41.25+4.97+13.7%$36.67$41.78$36.281,033,400
$36.28+1.82+5.3%$35.01$37.26$35.001,434,200
$34.46-1.58-4.4%$37.07$37.24$33.381,041,400
$36.04+1.91+5.6%$34.69$36.30$33.991,578,500
$34.13+2.45+7.7%$31.28$34.32$30.88982,100
$31.68-2.37-7.0%$33.72$34.36$31.121,112,300
$34.05+2.20+6.9%$39.45$40.50$33.027,310,200
$31.85-0.16-0.5%$31.96$33.28$30.71855,200
$32.01+1.42+4.6%$33.31$33.31$30.111,483,400
$30.59-0.80-2.5%$30.91$31.75$30.53355,500
$31.39-1.60-4.8%$33.02$33.02$30.96613,800
$32.99-0.29-0.9%$34.44$34.44$30.88667,800
$33.28-0.64-1.9%$34.45$35.41$32.501,167,900
$33.92-1.52-4.3%$35.20$36.03$33.77564,100
$35.44-0.54-1.5%$36.74$37.31$35.32610,600
$35.98-0.67-1.8%$36.61$36.80$34.99645,500
$36.65+2.23+6.5%$34.40$37.24$33.55674,500
$34.42-1.41-3.9%$35.82$35.82$33.66356,500
$35.83-0.83-2.3%$36.11$37.09$34.571,144,100
$36.66-4.37-10.7%$41.14$41.38$36.57658,400
$41.03+2.04+5.2%$39.43$42.24$39.37893,200
$38.99+0.39+1.0%$38.87$39.92$38.04661,300
$38.60-0.60-1.5%$40.20$41.48$38.452,590,700
$39.20+0.20+0.5%$39.91$41.90$39.13554,800
$39.00+0.53+1.4%$40.25$40.89$38.57637,200
$38.47+0.90+2.4%$37.22$39.02$35.98526,000
$37.57+1.13+3.1%$36.17$38.50$36.17442,600
$36.44-1.54-4.1%$38.08$38.30$35.49619,900
$37.98-1.59-4.0%$39.35$40.69$37.40389,100
$39.57-2.23-5.3%$40.74$42.79$39.31478,600
$41.80+1.34+3.3%$39.45$43.78$39.20540,700
$40.46-2.05-4.8%$41.06$42.00$40.38456,200
$42.51-2.77-6.1%$44.57$45.56$42.29717,000
$45.28+4.11+10.0%$44.48$47.98$44.261,365,300
$41.17-0.67-1.6%$41.57$42.62$40.75557,500
$41.84-0.020.0%$41.67$42.44$39.83687,000
$41.86-2.88-6.4%$44.36$44.74$41.69410,000
$44.74+0.55+1.2%$44.09$45.39$43.80375,300
$44.19-0.92-2.0%$45.84$45.84$43.73561,700
$45.11+1.83+4.2%$43.27$46.48$43.27441,929
$43.28+0.17+0.4%$43.47$44.64$42.56677,251
$43.11+1.21+2.9%$42.98$44.79$40.72528,000
$41.90-3.60-7.9%$45.50$45.99$41.78478,200
Ticker
NASDAQ:TRAX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All First Tracks Biotherapeutics, Inc. news

Financings

  • Private placement of shares of common stock

    Nov 3, 2026

    Closed: US$200M raised · US$32.75 a share · Leerink Partners +3

    Dealers: Leerink Partners, Piper Sandler, UBS Investment Bank, Wells Fargo Securities

    Buyers: Affinity Asset Advisors, LLC; First Light Asset Management; Sirenia Capital Management LP; TCGX; Trails Edge Capital Partners; Vestal Point Capital

    Use of proceeds: General corporate purposes, including clinical development of ANB033, a CD122 antagonist

    Announced Oct 15, 2026 · Closed Nov 3, 2026

Read by 6ix AI from the company's releases

Decks

First Tracks Biotherapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
10 in the last 12 months · 10 in all · newest Nov 3, 2026 · oldest 2026
Decks
1 deck · latest Oct 13, 2026

Where First Tracks Biotherapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:TRAX · Home listing · This pageNASDAQUnited StatesUSD
BMV:TRAXBMVMexicoMXN
BOATS:TRAXBOATSUnited StatesUSD
BIVA:TRAXBIVAMexicoMXN
Dusseldorf:B43DusseldorfGermanyUSD
Hamburg:B43HamburgGermanyEUR

Log in to ask 6ix AI your own questions about First Tracks Biotherapeutics, Inc.